Skip to main content

PCORI Awards UNC Researcher $14.4 Million to Study Emerging Medications for PIBD Patients

December 5, 2024
The Patient-Centered Outcomes Research Institute (PCORI) announced funding totaling $14.4 million for a Duke-UNC research collaboration to study new treatment options for pediatric inflammatory bowel diseases (PIBD). Michael D. Kappelman, MD, MPH, professor of pediatrics and epidemiology at the UNC School of Medicine, will serve as principal investigator. The Patient-Centered...

UNC Researchers to Accelerate Mapping of Cells Crucial to Child Respiratory Health and Disease

December 5, 2024
A research project co-led by James Hagood, MD, professor of pediatrics at the UNC School of Medicine, and colleagues will be supported in creating an atlas of the cells and cellular interactions in the nasal and oral cavities, throat, and lower airways of pediatric populations in unprecedented detail. Scale Biosciences announced...

Kappelman Leads Landmark Study Revealing That 100,000 American Youth Are Living with Inflammatory Bowel Disease

November 25, 2024
A comprehensive analysis published in the journal Gastroenterology and led by Michael D. Kappelman, MD, MPH, at the UNC School of Medicine, reveals that U.S. pediatric IBD rates have increased, ranking among the highest globally. A groundbreaking study published today in Gastroenterology provides the most comprehensive assessment to date of pediatric inflammatory...

Asthma Project Led by Hernandez et al Is One of Two Studies Awarded $1 Million by Novant Health

October 24, 2024
Novant Health has announced that it has, in collaboration with UNC Health and the UNC School of Medicine, awarded $1million to launch two clinical trials in North Carolina. One of the trials, co-led by Michelle Hernandez, MD, aims to reduce “health disparities for children with asthma.”

A New Therapy to Prevent or Delay Type 1 Diabetes Now Available at UNC Children’s Hospital

October 24, 2024
Nina Jain, MD, MBA, professor of pediatric endocrinology, and Ali Calikoglu, MD, retired professor of pediatrics, both at the UNC School of Medicine, played a pivotal role in getting this therapy to the bedside, from assisting with clinical trials to the infusion of the first pediatric patient in North Carolina...